Showing results (61-70 of 138) with videos related to
Sort By:
Pageof 14
Brain Research|May 11, 2010
Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cellsYoshikazu Tasaki, Tomohiro Omura, Takehiro Yamada, et al.Plos One|January 5, 2017
Time-Dependent Structural Alteration of Rituximab Analyzed by LC/TOF-MS after a Systemic Administration to RatsYuki Otani, Atushi Yonezawa, Masahiro Tsuda, et al.Molecular and Cellular Probes|October 1, 2013
Genotyping of 38 insertion/deletion polymorphisms for human identification using universal fluorescent PCRKumiko Oka, Masaru Asari, Tomohiro Omura, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 5, 2009
Detection of landiolol using high-performance liquid chromatography/fluorescence: a blood esterase-sensitive ultra-short-acting beta(1)-receptor antagonistManabu Suno, Takayuki Kunisawa, Akio Yamagishi, et al.Therapeutic Drug Monitoring|September 24, 2016
Population Pharmacokinetics of Everolimus in Relation to Clinical Outcomes in Patients With Advanced Renal Cell CarcinomaAtsuko Tanaka, Ikuko Yano, Keiko Shinsako, et al.Biochemical and Biophysical Research Communications|October 27, 2018
Ubiquitin ligase HMG-CoA reductase degradation 1 (HRD1) prevents cell death in a cellular model of Parkinson's diseaseTomohiro Omura, Hiroki Matsuda, Luna Nomura, et al.Cancer Chemotherapy and Pharmacology|February 17, 2017
Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemiaYoshitaka Nishikawa, Taro Funakoshi, Takahiro Horimatsu, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 3, 2005
Automation in drug inventory management saves personnel time and budgetToshio Awaya, Ko-ichi Ohtaki, Takehiro Yamada, et al.Journal of Pharmacological Sciences|November 18, 2019
Improvement of peripheral vascular impairment by a phosphodiesterase type 5 inhibitor tadalafil prevents oxaliplatin-induced peripheral neuropathy in miceTakashi Ogihara, Takayuki Nakagawa, Maho Hayashi, et al.CPT: Pharmacometrics & Systems Pharmacology|May 16, 2019
A Minimal Physiologically-Based Pharmacokinetic Model for Tacrolimus in Living-Donor Liver Transplantation: Perspectives Related to Liver Regeneration and the cytochrome P450 3A5 (CYP3A5) GenotypeKotaro Itohara, Ikuko Yano, Tetsunori Tsuzuki, et al.Pageof 14